The Jan. 20 summit seeks to develop a consensus regarding the management of patients who have Riata and Riata ST ICD leads.
[Business Wire, Jan. 7, 2012] Cardiovascular leaders will gather in Minneapolis for a one-day summit on Jan. 20, to review data for Riata and Riata ST implantable cardioverter-defibrillator (ICD) leads, which recently underwent a Class I FDA recall.
The summit directors are Robert G. Hauser, MD, senior cardiologist at the Minneapolis Heart Institute® at Abbott Northwestern Hospital and David L. Hayes, MD, professor of medicine. Read more at businesswire.com.